Featured Jobs
|
Defined Benefit Plan Consultant/Actuarial Analyst Sentinel Group
|
|
BPAS
|
|
MAP Retirement
|
|
Retirement Relationship Manager MAP Retirement
|
|
Pattison Pension
|
|
Plan Administrator, Defined Benefit & Cash Balance The Pension Source
|
|
Regional Vice President, Sales MAP Retirement
|
|
DWC - The 401(k) Experts
|
|
Strategic Retirement Plan Consultant Retirement Plan Consultants
|
|
Sentinel Group
|
|
MAP Retirement
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
GAO Testimony: Trends in FDA's Oversight of Direct-to-Consumer Advertising of Prescription Drugs
U.S. Government Accountability Office [GAO] 
May 9, 2008
19 pages. "GAO was asked to discuss trends in FDA's oversight of DTC advertising and the actions FDA has taken when it identifies violations. This statement is based on GAO's 2006 report, Prescription Drugs: Improvements Needed in FDA's Oversight of Direct-to-Consumer Advertising, GAO-07-54 (November 16, 2006). In this statement, GAO discusses the [1] DTC advertising materials FDA reviews, [2] FDA's process for issuing regulatory letters citing DTC advertising materials and the number of letters issued, and [3] the effectiveness of FDA's regulatory letters at limiting the dissemination of false or misleading DTC advertising." [GAO-08-758T, May 8, 2008]
|
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |